Laura Aguilar

Laura Aguilar

Net worth: 21 M $ as of 30/04/2024

59 year
Consumer Services
Health Technology

Network origin in Laura Aguilar first degree

EntityEntity typeIndustry
Public Company Biotechnology 19

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Laura Aguilar via their personal network

CompanySectorRelated peopleMain position
Medical Specialties

Glenn Mattes

Chief Tech/Sci/R&D Officer

IMMUNOGEN, INC. Biotechnology

Sandra E. Poole

Chief Tech/Sci/R&D Officer

TEXAS INSTRUMENTS INCORPORATED Semiconductors

Carrie Cox

Director/Board Member

Biotechnology

Paul Manning

Director/Board Member

Medical Specialties

Alan Smith

Susan Stewart

Sandra E. Poole

Chief Tech/Sci/R&D Officer

General Counsel

Corporate Officer/Principal

Miscellaneous Commercial Services

Susan Stewart

Director/Board Member

Internet Software/Services

Paul Manning

Director/Board Member

Pharmaceuticals: Major

Stephen Rocamboli

Fred H. Mermelstein

Founder

Founder

Biotechnology

Paul Manning

Director/Board Member

Pharmaceuticals: Major

Nathan Caffo

Chief Executive Officer

Pharmaceuticals: Major

Glenn Mattes

Chairman

Chemicals: Specialty

Glenn Mattes

Corporate Officer/Principal

City University of New York College/University

Glenn Mattes

Undergraduate Degree

Yale University College/University

Edward Benz

Christopher Martell

Graduate Degree

Undergraduate Degree

The Pennsylvania State University College/University

Nathan Caffo

Undergraduate Degree

The University of Waterloo College/University

Sandra E. Poole

Graduate Degree

University of Massachusetts College/University

Susan Stewart

Paul Manning

Undergraduate Degree

Undergraduate Degree

Food: Meat/Fish/Dairy

Paul Manning

Chief Executive Officer

Miscellaneous Commercial Services

Paul Manning

Director/Board Member

Financial Conglomerates

Paul Manning

Director/Board Member

Beta-Pro LLC

Paul Manning

Corporate Officer/Principal

The Presidential Advisory Council on HIV/AIDS General Government

Glenn Mattes

Corporate Officer/Principal

ARNO THERAPEUTICS, INC. Pharmaceuticals: Major

Glenn Mattes

Chief Executive Officer

Rhone-Poulenc Canada, Inc.

Glenn Mattes

President

Savings Banks

Paul Manning

Corporate Officer/Principal

Harvard Medical School College/University

Edward Benz

Shaan Gandhi

Corporate Officer/Principal

Doctorate Degree

Investment Managers

Paul Manning

Christopher Martell

Chief Executive Officer

Corporate Officer/Principal

REZOLUTE, INC. Pharmaceuticals: Major

Susan Stewart

General Counsel

Pharmaceuticals: Major

Paul Manning

Director/Board Member

Packaged Software

Paul Manning

Director/Board Member

ADVANZ PHARMA CORP. LIMITED Pharmaceuticals: Major

Paul Manning

Director/Board Member

Maurice A. Deane School of Law at Hofstra University College/University

Susan Stewart

Graduate Degree

Biotechnology

Paul Manning

Diem Nguyen

Chairman

Chief Executive Officer

VERRICA PHARMACEUTICALS INC. Pharmaceuticals: Major

Paul Manning

Diem Nguyen

Chairman

Director/Board Member

Pbm Capital Investments LLC

Paul Manning

Chief Executive Officer

Internet Software/Services

Paul Manning

Director/Board Member

DOVA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Paul Manning

Chairman

Pharmaceuticals: Major

Glenn Mattes

Director/Board Member

TFF PHARMACEUTICALS, INC. Pharmaceuticals: Major

Stephen Rocamboli

Glenn Mattes

Director/Board Member

Chief Executive Officer

Miscellaneous Commercial Services

Glenn Mattes

Chairman

Investment Managers

Glenn Mattes

Consultant / Advisor

Tibotec Therapeutics, Inc.

Glenn Mattes

President

ALX ONCOLOGY HOLDINGS INC. Biotechnology

Nathan Caffo

Corporate Officer/Principal

Statistics

International

United States 44
Canada 3
France 2
United Kingdom 2

Sectoral

Health Technology 24
Consumer Services 8
Finance 5
Commercial Services 4
Technology Services 4

Operational

Director/Board Member 105
Corporate Officer/Principal 44
Independent Dir/Board Member 26
Chairman 26
President 23
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW